Abstract Aim of the work: The aim of the present work was to determine the prevalence of infections in a cohort of Egyptian Systemic lupus erythematosus (SLE) patients and to describe their sites and relation to clinical characteristics, laboratory features and disease activity.
Introduction
Systemic lupus erythematosus (SLE) is a heterogeneous multisystem autoimmune disease [1] with protean manifestations, which may range from relatively minor skin and joint manifestations to severe life-threatening major organ involvement [2] . SLE is the second most common autoimmune disorder (after thyroid disease) in childbearing age women [3] . Many key events have been implicated in the pathogenesis of SLE such as cytokine overproduction [4, 5] , oxidative stress [6] and apoptosis [7] .
Several comorbidities such as metabolic syndrome [8] , dyslipidemia and atherosclerosis [9] could lead to functional disability, impaired quality of life and significantly affect the disease activity and damage. Survival rates for SLE patients have improved greatly with the ability to treat disease-specific manifestations and to lessen the impact of comorbid conditions [10] , but a three-to five-fold increased risk of death remains compared with the general population [3] .
Infections are among the most important causes of morbidity and mortality in SLE patients [11] . Despite the availability of newer therapeutic measures to improve clinical outcome in SLE patients, the incidence of infections as a cause of morbidity and mortality has not changed over the past 30 years [12] , and infection is still considered as one of the leading causes of morbidity and mortality in SLE patients [13] . Infection is responsible for approximately 25% of all deaths in patients with SLE, making it a leading cause of mortality in SLE [14] . The reasons which may explain the high incidence of infection in SLE are immunosuppressive therapy and immune disturbances of lupus itself, also infections can mimic disease flares in established SLE, leading to confusion over the diagnosis and appropriate treatment [13, 15] . There are several speculations on the contributory role of microbes in the induction and reactivation of chronic inflammatory and autoimmune conditions [16, 17] , although the reciprocity between pathogen and immune system dysregulation has not yet been clearly determined. These assumptions have largely emerged from the production of various autoantibodies during the course of many types of infections [2] . The main etiologic infectious agents in SLE patients are common bacterial pathogens, especially capsulated ones and the most commonly affected organs are lung, skin, bladder, brain and systemic infections [12] .
The aim of the present work was to determine the prevalence of infections in a cohort of Egyptian Systemic lupus erythematosus (SLE) patients and to describe their sites and relation to clinical characteristics, laboratory features and disease activity.
Patients and methods

Patients
Medical records of all Egyptian SLE patients attending the Rheumatology and Rehabilitation Department of Cairo University Hospitals during a 6 month period in 2011 were reviewed retrospectively for the demographic information, clinical features of the disease, immune profile, laboratory features, systemic lupus disease activity index (SLEDAI) and medical treatment. All of the patients fulfilled the updated American College of Rheumatology (ACR) revised criteria for the classification of SLE [18] . The study has been approved by local ethics committee and it conforms to the standards currently applied in the Cairo University Teaching Hospitals.
The patients were classified into two groups: Group 1: Patients who experienced at least one episode of infection and admitted to hospital or examined at least once by one of our physicians during infection episode. This group was classified as the infection group. The site of infection was also recorded.
Group 2: Those patients who had no relevant infectious episode and did not require hospital consultations or admission due to infection related complications.
Demographic features including age, sex, and time elapsed from SLE diagnosis were collected from medical charts. Detailed clinical characteristics and laboratory features were recorded. Results of immune profile including the antinuclear antibodies (ANA), anti-dsDNA and complement levels were also documented. The use of corticosteroids or immunosuppressive drugs was reviewed. The disease activity was assessed and recorded using Systemic Lupus Erythematosus disease activity index (SLEDAI) [19] at time of infection in group 1 and at the last visit for those in group 2.
Statistical analysis: Data were presented as numbers, percentage, mean ± SD. Mann-Whitney test was performed to compare between two non parametric groups. Chi square Pearson's test was performed to detect associations between categorical variables. Multiple linear regression analysis was performed to find the clinical, laboratory and medication predictive factors for infection in SLE.
Results
This study included 250 Egyptian SLE patients; their mean age was 27.38 ± 7.74 years with disease duration of 6.07 ± 4.08 years. They were 226 females and 24 males. Group 1 included 119 SLE patients with infection and Group 2 included 131 patients without infection. The clinical manifestations, medications received and disease activity are presented in Table 1 . The laboratory features of the studied patients are shown in Table 2 .
The SLE patients with infection were 111 females and 8 males with a mean age of 27.77 ± 8.30 years; their disease duration was 6.45 ± 4.21 years. SLE patients without infection were 115 females and 16 males with a mean age of 27.02 ± 7.11 years and disease duration of 5.72 ± 3.95 years.
Regarding the causative organisms, in the infection group, bacterial infection was the commonest as it was detected in 99 patients (83%) with staphylococcus aureus being the commonest, followed by fungal infection detected in 30 (25%) and viral infection in 22 (18.5%) patients. Combined infection with more than one causative organism was found in 34 patients (28.5%) while single pathogen infection was found in 85 patients (71.4%).
Regarding the sites of infection, the commonest site of infection was the skin (37%) followed by the urinary tract (31%) and chest (19%). Other sites with less frequency of affection were blood in 11%, vagina and knee joints in 9.2% each, oral cavity in 8.4% and other sites (e.g., Ear and nose) in 5%. The frequency of occurrence of infection at different sites is graphically presented in Fig. 1 .
There was no significant difference in the age (p = 0.44), gender (p = 0.14) or disease duration (p = 0.16) between the SLE patients with and without infection. A significant difference was found between the two groups regarding the disease activity (p < 0.001) and many other clinical characteristics and manifestations as presented in Table 1 . Secondary vasculitis was present in 5/119 (4.2%) of the SLE patients with infection while it was not present in those without infection. On the other hand, deep venous thrombosis occurred in 2 patients without infection. Table 2 shows the laboratory features of the SLE patients with and without infection. On performing a logistic regression analysis, only SLEDAI (p < 0.001) and CRP (p < 0.001) were significant predictors of infection.
Discussion
Infections are one of the leading causes of morbidity and mortality in patients with SLE [20] [21] [22] . Infection is responsible for approximately 25% of all deaths in SLE patients, making it a leading cause of mortality [14] , on the other hand infections are known to be major environmental factor that has been shown to be highly associated with the development of SLE especially Epstein-Barr virus (EBV) infection [17, 23] . In-spite of the variations in studies' designs, duration of follow-up, methods of patients' selection, the rate of infection in lupus patients was always found to be high. In our study it was found to be 47.6%, which is comparable to what was noted by other investigators (58.79%) [24] , (32%) [25] and (36%) [26] .
Skin infection was the most common site as it occurred in 37% of the infection group; other common sites of infection included the urinary tract in 31%, chest in 19%, blood in 11%, vagina and knee joints in 9.2% each, oral cavity in 8.4% and other sites (e.g., Ear and nose) in 5%. The higher prevalence of skin and urinary tract (UT) infection in our patients was also reported by Zonana-Nacach et al. [25] where UT infection was found in 26% and skin infection in 23% of the total infections. The role of bacterial pathogens in infection in lupus patients [12, 24, 27] was also documented in our study and bacterial infection was found in 83% of the cases most of which were Staphylococcus aureus. Increased relapse rate was found in SLE patients with Staphylococcus aureus infection compared to those without [28] .
In the current study, a significant difference was found between the two groups regarding many clinical manifestations as oral ulcers and neuropsychiatric as well as the CRP and the SLEDAI, however after regression analysis only CRP (p < 0.001) and SLEDAI (p < 0.001) were found to be significant predictors of infection. Such results may indicate that elevated CRP can be used as a marker of active infection in SLE with high specificity and it confirms the results of several reports about the importance of CRP as a biomarker of infection in lupus patients [17, [29] [30] [31] .
On the other hand, elevated SLEDAI is an independent risk factor for mortality in patients with SLE [22] and its association with infection in this study even after regression analysis (p < 0.001) was not surprising. In our opinion SLEDAI is a compound risk factor as active disease may be associated with chest complication, weak muscles, complement deficiency, extensive need for immunosuppressive medications, bed ridden patients and prolonged hospital stay, and all of these factors can be considered as risk factors for infection and this is in line with what was stated by Al-Rayes et al. [24] as they reported that the high incidence of infections in SLE patients may be attributed to the multiple intrinsic and extrinsic risk factors including deficiency of complement (C3 and C4), disease activity, renal impairment, use of glucocorticoid and cytotoxic drugs. Also Duffy et al. [32] found that by logistic regression analysis, infection was significantly associated with disease activity (p = 0.005), but not with disease duration or prednisone dosage, while Navarro-Zarza et al. [33] reported that risk factors for infection include disease activity, use of immunosuppressants, disease duration, and length of hospital stay.
In fact, different studies may show different risk factors of infection in lupus patients, however in most of these studies disease activity is a common risk factor [25, 26, 30, 34] . Even Zonana-Nacach et al. [25] reported that at infection onset 77% of patients had elevated disease activity, with a mean SLEDAI score of 6.1 and that the variables significantly associated with infection were the presence of disease activity, SLEDAI score, renal activity, prednisone dose and receiving cyclophosphamide; however, the only variable associated with infection in the multivariate analyses was a SLEDAI score of 4 or higher.
It could be concluded that high disease activity in lupus is an important predictor for infection. Every attempt should be done to control the disease activity using the least possible doses of immunosuppressive drugs with close monitoring of patients to reduce the risk of increased morbidity and mortality in lupus patients due to infection. 
